Notably, however, the effect of this co‐occurrence on cancer cell survival depends on the tissue in which both mTORC1 and TFEB are hyperactive; for example, TFEB‐mTORC1 hyperactivity can allow tumour‐associated macrophages to outcompete cancer cells (Zhang et al, 2023). This evidence concerns the gene TFEB and cancer.